States that do provide coverage have tried to manage costs by putting prescribing limits on the GLP-1s. There's also some ...

The Trump administration has decided not to go forward with a proposal for Medicare and Medicaid to cover high-demand obesity ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the ...

The decision is a setback for GLP-1 drugmakers, though it's not entirely surprising given the Trump administration’s focus on ...

I’M MINDY BASARA IN TODAY’S MEDICAL ALERT, WEIGHT LOSS AND DIABETES DRUGS LIKE OZEMPIC WEGOVY ... the medications under Medicare's Part D prescription drug coverage. Medicare covers health ...

The Senate confirmed Dr. Mehmet Oz to lead ... opponent of the injectable drugs, which have exploded in popularity due to the potentially life-changing weight loss that some patients experience.

The Centers for Medicare and Medicaid Services said late Friday that it would not cover the medications under Medicare’s Part D prescription ... drugs, which have exploded in popularity due to the ...

A prescription ... Dr Lara Courtenay says this medication is meant to help Kiwis who are seriously struggling with obesity. "All the studies were actually done with a very low-calorie diet ...